Enox Biopharma Inc 3 SEC Filings

Filed On	Filing
03 Jan 2011	Form 3: Rewcastle John Cameron, Chief Executive Officer No securities owned
11 Mar 2010	Form 3: Avniel Amir, Director Holds 0 shares of No securities are beneficially owned
31 Jul 2009	Form 3: David Itamar, Chief Financial Officer Holds 299,361 shares of Common Stock
07 May 2009	Form 3: Miller Chris, Director Holds 400,000 shares of Common Stock
12 Dec 2008	Form 3: Greenberg David, Director Holds 400,000 shares of Common Stock
24 Nov 2008	Form 3: Mizrahi Razi, Director Holds 675,000 shares of Common Stock
24 Nov 2008	Form 3: Av-Gay Yossef, Director Holds 5,275,000 shares of Common Stock

Comments